NCT05450172

Brief Summary

Postoperative transitional pain corresponds to the pain occuring between acute postoperative pain and chronic postsurgical pain (defined as pain persisting for at least 3 months after surgery). We hypothesized that both trajectory and neuropathic component of transitional pain may influence the quality of recovery after thoracic surgery. To test this, we designed an observational study to identify risk factors for incomplete recovery assessed through the QoR-15 questionnaire.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
204

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 5, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 8, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

October 10, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2024

Completed
Last Updated

December 30, 2025

Status Verified

December 1, 2025

Enrollment Period

1.4 years

First QC Date

July 5, 2022

Last Update Submit

December 23, 2025

Conditions

Keywords

Postoperative transitional painpostoperative pain trajectorypostoperative neuropathic painthoracic surgery

Outcome Measures

Primary Outcomes (1)

  • Impact of pain trajectory and neuropathic component of pain on quality of recovery.

    An incomplete recovery will be defined as a postoperative QoR-15 score of at least 8 points lower than the preoperative QoR-15 value. The association between both trajectory and neuropathic component of postoperative transitional pain and incomplete recovery will be evaluated.

    3 months after surgery.

Secondary Outcomes (5)

  • Description of trajectory and neuropathic component of postoperative transitional pain.

    Between postoperative day 2 and 3 months after surgery.

  • Impact of the type of surgery on quality of recovery.

    3 months after surgery.

  • Impact of pain trajectory, neuropathic component of pain and type of surgery on chronic postsurgical pain prevalence.

    3 and 6 months after surgery.

  • Predictive accuracy of neuropathic pain trajectory on incomplete recovery and chronic postsurgical pain prevalence.

    3 and 6 months after surgery.

  • Correlation between neuropathic componente of chronic postsurgical pain and quality of recovery.

    3 and 6 months after surgery.

Study Arms (1)

Consecutive patients scheduled for thoracic surgery

Other: QoR-15 questionnaire

Interventions

The QoR-15 is a 15-item questionnaire on postoperative quality of recovery. The DN4 is a 10-item questionnaire on neuropathic pain. Both questionnaires will be given to the patients preoperatively, on postoperative days 2 and 3, and 1, 3 and 6 months after surgery.

Also known as: DN4 questionnaire
Consecutive patients scheduled for thoracic surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients scheduled for thoracic surgery (thoracotomy or video-assisted thoracic surgery or surgery for thoracic outlet syndrome).

You may qualify if:

  • adult patients
  • patients scheduled for thoracic surgery (thoracotomy or video-assisted thoracic surgery or surgery for thoracic outlet syndrome)
  • patients who do not object to the study

You may not qualify if:

  • patients non francophone
  • emergency surgery or revision surgery
  • patients already included in the study during the previous 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU

Angers, 49933, France

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 5, 2022

First Posted

July 8, 2022

Study Start

October 10, 2022

Primary Completion

March 10, 2024

Study Completion

June 10, 2024

Last Updated

December 30, 2025

Record last verified: 2025-12

Locations